1. Home
  2. CTXR vs INBS Comparison

CTXR vs INBS Comparison

Compare CTXR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • INBS
  • Stock Information
  • Founded
  • CTXR 2007
  • INBS 2016
  • Country
  • CTXR United States
  • INBS United States
  • Employees
  • CTXR N/A
  • INBS N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • INBS Medical Specialities
  • Sector
  • CTXR Health Care
  • INBS Health Care
  • Exchange
  • CTXR Nasdaq
  • INBS Nasdaq
  • Market Cap
  • CTXR 14.6M
  • INBS 16.4M
  • IPO Year
  • CTXR N/A
  • INBS N/A
  • Fundamental
  • Price
  • CTXR $1.03
  • INBS $1.44
  • Analyst Decision
  • CTXR Strong Buy
  • INBS
  • Analyst Count
  • CTXR 2
  • INBS 0
  • Target Price
  • CTXR $54.50
  • INBS N/A
  • AVG Volume (30 Days)
  • CTXR 598.0K
  • INBS 144.8K
  • Earning Date
  • CTXR 05-13-2025
  • INBS 05-07-2025
  • Dividend Yield
  • CTXR N/A
  • INBS N/A
  • EPS Growth
  • CTXR N/A
  • INBS N/A
  • EPS
  • CTXR N/A
  • INBS N/A
  • Revenue
  • CTXR N/A
  • INBS $3,031,405.00
  • Revenue This Year
  • CTXR N/A
  • INBS $280.88
  • Revenue Next Year
  • CTXR N/A
  • INBS $126.26
  • P/E Ratio
  • CTXR N/A
  • INBS N/A
  • Revenue Growth
  • CTXR N/A
  • INBS 23.21
  • 52 Week Low
  • CTXR $1.15
  • INBS $1.00
  • 52 Week High
  • CTXR $26.25
  • INBS $4.09
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 27.09
  • INBS 31.91
  • Support Level
  • CTXR $1.21
  • INBS $1.34
  • Resistance Level
  • CTXR $2.28
  • INBS $2.21
  • Average True Range (ATR)
  • CTXR 0.20
  • INBS 0.18
  • MACD
  • CTXR -0.00
  • INBS -0.07
  • Stochastic Oscillator
  • CTXR 0.71
  • INBS 11.93

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

Share on Social Networks: